Can the Use of a Next Generation Partograph Improve Neonatal Outcomes? (PICRINO)
Can the Use of a Next Generation Partograph Based on WHO's Latest Intrapartum Care Recommendations Improve Neonatal Outcomes? A Stepped-wedge Cluster Randomized Trial (PICRINO)
The overall aim is to evaluate the impact of the use of two different guidelines for monitoring labor progress, the WHOs LCG versus standard care, on neonatal and maternal outcomes. The hypothesis is that the use of LCG will reduce adverse neonatal outcomes and decrease the number of intrapartum Cesarean sections compared with standard care.
Secondly, other perinatal interventions and complications will be compared between the LCG and standard care groups, as well as economic considerations. This will be investigated using a multicenter, stepped-wedge cluster randomized trial design.
In addition, the project will explore a series of quantitative and qualitative research questions to gain in-depth knowledge about experiences and perceptions about childbirth and the use of LCG. These research questions will be investigated using questionnaires, focus group and individual interviews with providers, partners and women that have gone through childbirth.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Title
Can the use of a next generation partograph based on WHO's latest intrapartum care recommendations improve neonatal outcomes? A stepped-wedge cluster randomized trial (PICRINO).
Primary Objectives
To compare two different guidelines for monitoring labor progress, the the World Health Organization (WHO)'s Labour Care Guide (LCG) with standard care, and evaluate:
Adverse neonatal outcome, a composite outcome of perinatal mortality and neonatal morbidity. Neonatal morbidity will include five-minute Apgar score <7, hypoxic ischemic encephalopathy II-III, intracranial hemorrhage, neonatal seizures, meconium aspiration syndrome, and admission to a neonatal unit.
The rate of intrapartum cesarean section.
Secondary Objectives
Secondary outcomes will be a composite of severe neonatal outcomes including five-minute Apgar score <4, hypoxic ischemic encephalopathy II-III, intracranial hemorrhage, neonatal seizures and meconium aspiration syndrome and other relevant neonatal outcomes.
Obstetric outcomes will be mode of delivery, oxytocin use, postpartum hemorrhage, perineal laceration (grade II-IV), duration of labor, women´s and partner´s experiences of childbirth, healthcare providers experiences of and compliance to LCG and economic considerations.
Study Design
A multicenter, stepped-wedge cluster randomized trial.
Study Population
All women in active labor at participating delivery units in Sweden.
Power analysis
With significance level 0.05, the power to detect the anticipated risk reduction (20%) would be >0.999.
Study Duration
2023-2025
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Eksjö, Sweden
- Eksjö höglandssjukhuset
-
Falun, Sweden
- Falu Lasarett
-
Gothenburg, Sweden
- Göteborg Salgrenska Universitetssjukhuset
-
Gällivare, Sweden
- Gällivare sjukhus
-
Helsingborg, Sweden
- Helsingborgs lasarett
-
Huddinge, Sweden
- Huddinge Karolinska universitetssjukhus
-
Hudiksvall, Sweden
- Hudiksvalls sjukhus
-
Jönköping, Sweden
- Jönköping Länssjukhuset Ryhov
-
Kalmar, Sweden
- Länssjukhuset
-
Kristianstad, Sweden
- Kristianstad centralsjukhus
-
Linköping, Sweden
- Linköpings universitetssjukhus
-
Lund, Sweden
- Lund Skånes universitetssjukhus
-
Skellefteå, Sweden
- Skellefteå Lasarett
-
Stockholm, Sweden
- BB Stockholm
-
Stockholm, Sweden
- Stockholm Södersjukhuset
-
Södertälje, Sweden
- Södertälje Sjukhus
-
Södra Sunderbyn, Sweden
- Sunderby sjukhus
-
Umeå, Sweden
- Umeå Norrlands universitetssjukhus
-
Uppsala, Sweden
- Akademiska sjukhuset
-
Visby, Sweden
- Visby Lasarett
-
Värnamo, Sweden
- Värnamo sjukhus
-
Västervik, Sweden
- Västerviks sjukhus
-
Ystad, Sweden
- Ystad Lasarett
-
-
Östergötland County
-
Norrköping, Östergötland County, Sweden
- Vrinnevisjukhuset
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-All women in active labor
Exclusion Criteria:
-No exclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Labour care guide
According to WHO guidelines |
Guidelines for monitoring labor progress, the WHOs LCG |
|
No Intervention: Standard care
Standard delivery care in Sweden |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adverse neonatal outcome
Time Frame: 12 weeks up to 18 months
|
a composite outcome of perinatal mortality and neonatal morbidity. Neonatal morbidity will include five-minute Apgar score <7, hypoxic ischemic encephalopathy II-III, intracranial hemorrhage, neonatal seizures, meconium aspiration syndrome, and admission to a neonatal unit. |
12 weeks up to 18 months
|
|
The rate of intrapartum cesarean section
Time Frame: 12 weeks up to 18 months
|
The rate of intrapartum cesarean section |
12 weeks up to 18 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Neonatal outcomes
Time Frame: 12 weeks up to 18 months
|
Five-minute Apgar score <7 admission to neonatal unit Hypoxic ischemic encephalopathy II-III Intracranial hemorrhage Neonatal seizures Meconium aspiration syndrome Five-minute Apgar score <4 Perinatal mortality neonatal mortality Neonatal infection Neonatal hypoglycemia Neonatal jaundice Shoulder dystocia Obstetric brachial plexus injury |
12 weeks up to 18 months
|
|
Obstetric outcomes
Time Frame: 12 weeks up to 18 months
|
Rates of spontaneous vaginal delivery Rates of instrumental delivery Indications for intrapartum cesarean section Rates of oxytocin use for augmentation of labor Cervical dilation at onset of augmentation (centimeters) Rates of adherence to oxytocin use recommendations Rates of epidural use Amount of postpartum bleeding, ml Rates of perineal laceration (grade II-IV) Duration of labor, minutes |
12 weeks up to 18 months
|
|
Childbirth experience (women and partners)
Time Frame: 12 weeks up to 18 months
|
interviews questionaries |
12 weeks up to 18 months
|
|
Provider experience of LCG
Time Frame: 12 weeks up to 18 months
|
interviews |
12 weeks up to 18 months
|
|
Economic evaluation
Time Frame: 12 weeks up to 18 months
|
Data on health care utilization for women Data on health care utilization for children |
12 weeks up to 18 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Marie Blomberg, Professor, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Publications and helpful links
General Publications
- WHO recommendations: Intrapartum care for a positive childbirth experience. Geneva: World Health Organization; 2018. Available from http://www.ncbi.nlm.nih.gov/books/NBK513809/
- Vogel JP, Comrie-Thomson L, Pingray V, Gadama L, Galadanci H, Goudar S, Laisser R, Lavender T, Lissauer D, Misra S, Pujar Y, Qureshi ZP, Amole T, Berrueta M, Dankishiya F, Gwako G, Homer CSE, Jobanputra J, Meja S, Nigri C, Mohaptra V, Osoti A, Roberti J, Solomon D, Suleiman M, Robbers G, Sutherland S, Vernekar S, Althabe F, Bonet M, Oladapo OT. Usability, acceptability, and feasibility of the World Health Organization Labour Care Guide: A mixed-methods, multicountry evaluation. Birth. 2021 Mar;48(1):66-75. doi: 10.1111/birt.12511. Epub 2020 Nov 22.
- Sjoberg J, Ramo Isgren A, Abrahamsson T, Blomberg M, Thomas K. Associations between organizational readiness and implementation fidelity in national implementation of WHO's labour care guide in Sweden: a prospective observational study. Implement Sci Commun. 2026 Aug 14;7(1):165. doi: 10.1186/s43058-026-01073-z.
- Isgren AR, Korsoski R, Abrahamsson T, Wendel SB, Kallen K, Lundborg L, Remaeus K, Thomas K, Wikstrom AK, Carlsson Y, Blomberg M. Can the use of a next generation partograph based on WHO's latest intrapartum care recommendations improve neonatal outcomes? (PICRINO) Study protocol for a stepped-wedge cluster randomized trial. PLoS One. 2025 Mar 4;20(3):e0316336. doi: 10.1371/journal.pone.0316336. eCollection 2025.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- Picrino2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
At present we are not allowed to share anonymized data extracted from Swedish medical health registers
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.